EntreMed, Inc. researches and develops biopharmaceutical products that focus on the role of blood and blood vessels in health and disease. The Company's products present antiangiogenic solutions to cancer, cardiovascular disease, and macular degeneration. Therapeutics currently being researched include Endostatin and Angiostatin.